736 A clinical stage engineered toxin body (ETB) targeting PD-L1 (MT-6402) induces peripheral pharmacodynamic responses unique from PD-L1 monoclonal antibodies

Autor: Swati Khanna, Rachael Orlandella, Elizabeth Saputra, Sydney Matthews, Lydia Navarrete-Galvan, Sara LeMar, Joseph Dekker, Eric Poma, Chris Moore
Rok vydání: 2022
Zdroj: Regular and Young Investigator Award Abstracts.
DOI: 10.1136/jitc-2022-sitc2022.0736
Databáze: OpenAIRE